Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

IntraDose receives orphan drug status for melanoma indication

Sep. 22, 2000

Genta presents clinical trial update for Genasense

Sep. 22, 2000

Thalidomide improves tolerability of irinotecan in colorectal cancer patients

Sep. 22, 2000

Esculentins extracted from plant and found to exert antiinflammatory, antitumor effects

Sep. 21, 2000

2-5A antisense compound effective against malignant glioma and prostate cancer in mice

Sep. 21, 2000

Photofrin effective in treatment of Barrett's esophagus-related dysplasia

Sep. 21, 2000

BLA resubmitted for Bexxar

Sep. 21, 2000

Matrix metalloproteinase-inhibitory compounds described in recent patent

Sep. 20, 2000

uPAR antagonists claimed by Roche Diagnostics as antitumor/antimetastatic agents

Sep. 20, 2000

Phase I Oncolym study begins for relapsed and refractory B-cell lymphoma

Sep. 19, 2000

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...